Peptidream, Inc.Peptidream, Inc.Peptidream, Inc.

Peptidream, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.27 B‬USD
−0.30USD
‪95.49 M‬USD
‪296.86 M‬USD
‪96.26 M‬
Beta (1Y)
1.34
Employees (FY)
621
Change (1Y)
+18 +2.99%
Revenue / Employee (1Y)
‪478.04 K‬USD
Net income / Employee (1Y)
‪153.78 K‬USD

About Peptidream Inc.


CEO
Patrick Crawford Reid
Headquarters
Kawasaki
Founded
2006
ISIN
JP3836750004
FIGI
BBG006Z5JGT9
PeptiDream, Inc. engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. It operates through Drug Discovery and Development Business segment. The Drug Discovery and Development Business segment provides macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS) and engages in collaborative drug discovery research and development, technology licensing of PDPS, and expansion of pipeline through strategic alliances. The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.

Check out other big names from the same industry as PPTDF.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
1306
Next Funds TOPIX Exchange Traded Fund
Weight
0.02%
Market value
‪28.68 M‬
USD
1308
Nikko Exchange Traded Index Fund TOPIX
Weight
0.02%
Market value
‪13.29 M‬
USD
1305
iFreeETF TOPIX
Weight
0.02%
Market value
‪13.05 M‬
USD
1348
MAXIS TOPIX ETF
Weight
0.02%
Market value
‪3.98 M‬
USD
2837
Global X Japan Mid & Small Cap Leaders ETF Units
Weight
2.28%
Market value
‪3.48 M‬
USD
1475
iShares Core TOPIX ETF
Weight
0.02%
Market value
‪2.39 M‬
USD
1593
MAXIS JPX-Nikkei Index 400 ETF
Weight
0.02%
Market value
‪1.42 M‬
USD
2B78
iShares Healthcare Innovation UCITS ETF
Weight
0.12%
Market value
‪1.29 M‬
USD
IJPA
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪1.05 M‬
USD
0A3F
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪1.05 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of PPTDF is 12.19 USD — it has increased by 11.38% in the past 24 hours. Watch Peptidream, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Peptidream, Inc. stocks are traded under the ticker PPTDF.
PPTDF stock has risen by 11.38% compared to the previous week, the month change is a 19.04% rise, over the last year Peptidream, Inc. has showed a −28.29% decrease.
We've gathered analysts' opinions on Peptidream, Inc. future price: according to them, PPTDF price has a max estimate of 28.32 USD and a min estimate of 16.73 USD. Watch PPTDF chart and read a more detailed Peptidream, Inc. stock forecast: see what analysts think of Peptidream, Inc. and suggest that you do with its stocks.
PPTDF reached its all-time high on Jun 17, 2015 with the price of 113.75 USD, and its all-time low was 7.40 USD and was reached on Oct 31, 2023. View more price dynamics on PPTDF chart.
See other stocks reaching their highest and lowest prices.
PPTDF stock is 11.05% volatile and has beta coefficient of 1.34. Track Peptidream, Inc. stock price on the chart and check out the list of the most volatile stocks — is Peptidream, Inc. there?
Today Peptidream, Inc. has the market capitalization of ‪1.26 B‬, it has increased by 7.19% over the last week.
Yes, you can track Peptidream, Inc. financials in yearly and quarterly reports right on TradingView.
Peptidream, Inc. is going to release the next earnings report on Feb 18, 2026. Keep track of upcoming events with our Earnings Calendar.
PPTDF earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.05 USD resulting in a −11.87% surprise. The estimated earnings for the next quarter are 0.02 USD per share. See more details about Peptidream, Inc. earnings.
Peptidream, Inc. revenue for the last quarter amounts to ‪29.16 M‬ USD, despite the estimated figure of ‪30.99 M‬ USD. In the next quarter, revenue is expected to reach ‪52.02 M‬ USD.
PPTDF net income for the last quarter is ‪−7.40 M‬ USD, while the quarter before that showed ‪−7.56 M‬ USD of net income which accounts for 2.07% change. Track more Peptidream, Inc. financial stats to get the full picture.
No, PPTDF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 8, 2025, the company has 621 employees. See our rating of the largest employees — is Peptidream, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Peptidream, Inc. EBITDA is ‪−34.28 M‬ USD, and current EBITDA margin is 50.65%. See more stats in Peptidream, Inc. financial statements.
Like other stocks, PPTDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Peptidream, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Peptidream, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Peptidream, Inc. stock shows the sell signal. See more of Peptidream, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.